Potential of oral combination lipid‑lowering therapy beyond statins: a simulation‑based perspective from the SANTORINI study

Benzer Materyaller

• Network Meta‐Analysis of Randomized Trials Evaluating the Comparative Efficacy of Lipid‐Lowering Therapies Added to Maximally Tolerated Statins for the Reduction of Low‐Density Lipoprotein Cholesterol
  Yazar:: Peter P. Toth, ve diğerleri
  Baskı/Yayın Bilgisi: (2022-09-01)
• Efficacy and safety of lipid-lowering therapies in combination with or without statin to reduce the cardiovascular risk: A systematic review of randomised controlled trials
  Yazar:: Gabriella Iannuzzo, ve diğerleri
  Baskı/Yayın Bilgisi: (2024-12-01)
• The Pleiotropic Effects of Lipid-Modifying Interventions: Exploring Traditional and Emerging Hypolipidemic Therapies
  Yazar:: Dimitris Kounatidis, ve diğerleri
  Baskı/Yayın Bilgisi: (2024-07-01)
• Triple Non-Statin Therapy with Ezetimibe, Inclisiran, and Bempedoic Acid in Patients with Genetically Confirmed Statin-Induced Rhabdomyolysis: A Dual Case Report
  Yazar:: Jozef Dodulík, ve diğerleri
  Baskı/Yayın Bilgisi: (2025-05-01)
• Sex differences in pathogenesis and treatment of dyslipidemia in patients with type 2 diabetes and steatotic liver disease
  Yazar:: Tatjana Ábel, ve diğerleri
  Baskı/Yayın Bilgisi: (2024-09-01)